TickerFacts.

PRF Technologies Ltd. (PRFX): Operating Income

Annual figures by period end, from SEC filings.

-$5.12M
Year ended 2025-12-31
2018-12-31: -$500.0K2019-12-31: -$689.0K2020-12-31: -$1.67M2021-12-31: -$7.21M2022-12-31: -$8.87M2023-12-31: -$9.58M2024-12-31: -$14.67M2025-12-31: -$5.12M-$5.12M
2018-12-31 Operating Income (USD) 2025-12-31
Period endedOperating IncomeChange YoYSource filing
2025-12-31-$5.12Mn/m2026-03-26, From 2025-01-01
2024-12-31-$14.67Mn/m2026-03-26, From 2024-01-01
2023-12-31-$9.58Mn/m2026-03-26, From 2023-01-01
2022-12-31-$8.87Mn/m2025-04-07, From 2022-01-01
2021-12-31-$7.21Mn/m2024-02-29, From 2021-01-01
2020-12-31-$1.67Mn/m2023-03-15, From 2020-01-01
2019-12-31-$689.0Kn/m2022-03-16, From 2019-01-01
2018-12-31-$500.0Kn/a2021-03-18, From 2018-01-01

Operating Income at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedOperating IncomeChange YoY
PRF Technologies Ltd. (PRFX)2025-12-31-$5.12Mn/m
Bioadaptives, Inc. (BDPT)2025-12-31-$1.04Mn/m
Skinvisible, Inc. (SKVI)2025-12-31-$496.3Kn/m
Jupiter Neurosciences, Inc. (JUNS)2025-12-31-$8.91Mn/m
Talphera, Inc. (TLPH)2025-12-31-$13.48Mn/m
Impact Biomedical Inc. (IBO)2025-12-31-$4.28Mn/m
Lyell Immunopharma, Inc. (LYEL)2025-12-31-$269.40Mn/m
Genelux Corp (GNLX)2025-12-31-$33.21Mn/m
Neonc Technologies Holdings, Inc. (NTHI)2025-12-31-$58.24Mn/m

Compare PRFX, BDPT, SKVI, JUNS side by side · Screen every company in Pharmaceutical Preparations ↗